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Abstract.  A  clonal strain of human lung tumor cells 
in culture (ChaGo),  derived from a bronchogenic car- 
cinoma,  synthesizes and secretes large amounts of al- 
pha (ix) and a comparatively lower level of beta (/~) 
subunit of the glycoprotein hormone,  human chorionic 
gonadotropin (HCG). ChaGo cells lost their character- 
istic anchorage-independent  growth phenotype in the 
presence of anti-ot-HCG antibody. The effect of the 
antibody was partially reversed by addition of ot-HCG 
to the culture medium. 
ChaGo cells were transfected with an expression 
vector (pRSV-anti-ot-HCG), that directs synthesis of 
RNA complementary to o~-HCG mRNA.  The transfec- 
tants produced tx-HCG antisense RNA which was as- 
sociated with the reduced level of cz-HCG.  Transfec- 
tants also displayed several altered phenotypic proper- 
ties,  including altered morphology,  less mitosis,  re- 
duced growth rate,  loss of anchorage-independent 
growth,  and loss of tumorigenicity in nude mice. 
Treatment of transfectants with 8,bromo-cAMP 
resulted in increased accumulation of a-HCG mRNA, 
no change in the level of tx-HCG antisense RNA, re- 
lease of the inhibition of [3H]thymidine incorporation, 
and restoration of anchorage-independent  growth 
phenotype. The overexpression of c-myc, observed in 
ChaGo cells, was unaffected by the reduced level of 
ot-HCG. 
These results suggest that ectopic synthesis of the al- 
pha subunit of HCG plays a  functional role in the 
transformation  of these human lung cells. 
UNG cells that have undergone transformation  frequently 
acquire the property of ectopically synthesizing  and 
secreting hormones (26). The predominant hormone 
synthesized  by many different types of human lung tumors 
is the human chorionic gonadotropin  (HCG) t (5, 11, 12, 28, 
34). The association of neoplasia with HCG is so great that 
the increased levels of circulating  HCG and its subunits are 
used as a biochemical marker for malignancy  and as a cri- 
terion  for the successful surgical  removal  of such  tumors. 
However, it is not known whether such ectopically synthe- 
sized hormones play a functional  role in the tumorigenesis 
process. 
Under physiological  conditions,  HCG is synthesized  by 
syncytiotropoblast cells at the very early stages of pregnancy. 
Consistent production of this  hormone is essential  for the 
growth,  development, and maintenance  of the fetus during 
the gestation  period.  The possibility that  HCG may  also 
serve as a growth factor in the neoplastic transformation  of 
cells is explored in this  investigation.  This is achieved  by 
interfering  in the synthesis of the hormone in the HCG-pro- 
ducing  human lung tumor cells in culture. 
It has been demonstrated that microinjection of antibodies 
to synthetic antigens  affected the morphology and function 
1. Abbreviation used in this paper:  HCG, human chorionic gonadotropin. 
of cells in culture (3,  38).  For example,  microinjection of 
anti-ras  protein  antibody into  cultured normal  rat kidney 
cells transiently  reversed the transformed phenotype of these 
cells (8, 9, 21). Another experimental approach that has been 
used by several investigators  is to inhibit  the translation  of 
mRNA by formation of RNA duplexes with the complemen- 
tary antisense  RNA (18, 19, 23). This is achieved either by 
introducing a recombinant plasmid expression vector, which 
generates  antisense  RNA, or by microinjection of the spe- 
cific antisense  RNA species itself (15, 39).  By these means 
it has been possible to inhibit  the synthesis  of a variety of 
cell-specific  proteins (20, 23-25).  Inducible production of 
c-fos-antisense  RNA inhibits proliferation  of 3T3 cells (17) 
and introduction  of protooncogene c-fos-antisense RNA in- 
hibited the platelet-derived  growth factor-induced growth of 
mouse 3T3 cells that express c-fos (24).  In some instances, 
only a transient  effect can be observed because of the induc- 
tion of an unwinding protein by the RNA duplexes (2, 29, 37). 
In this investigation, we have examined the role of c~-HCG 
on the regulation  of growth of ChaGo cells by specifically 
reducing  the hormone level as the consequence of (a) addi- 
tion of anti-tx-HCG antibody in the culture media; and also 
by (b)  intracellular  synthesis  of o~-HCG-specific antisense 
RNA  from  an  expression  vector  (Rous  sarcoma  virus 
[pRSV]-anti-ct-HCG). Both maneuvers led to severe altera- 
tion of the transformation  phenotypes of ChaGo cells. 
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7Issue Culture 
All cells were grown in Ham's F-10 medium (Gibco Laboratories, Grand 
Island, NY) supplemented with 10% fetal bovine serum at 37°C in 95% air 
and 5%  CO2. 
Growth in Soft Agar 
5  x  104 ceils were uniformly dispersed over top agar (minimal essential 
medium supplemented with 10%  fetal bovine serum and 0.3% bactoagar) 
and were overlayered on the bottom agar (minimal essential medium sup- 
plemented with 10 % fetal bovine serum and 0.6 % bactoagar), and incubated 
at 37°C in 95% air and 5% CO2.  Phase-contrast microscopy was used to 
monitor colony formation and to obtain photographs. 
Colony forming efficiency was quantitated 28 d after seeding 3  x  104 
cells. Any growth which attained a diameter >/0.2 mm was considered to 
be a countable colony. A total of  500 colonies and cells in several representa- 
tive felds were scored in each plate. In cases where very few or no colonies 
were formed (such as in the presence of maximum concentration of a-HCG 
antibody and when 3T3 cells were used), the total number of colonies in 
the whole plate was counted. Results were expressed as percent colonies 
formed per total number of seeded cells. 
Construction  and Characterization  of the Plasmid 
Expression Vector  pRSV-Anti-~-HCG 
The construction protocol and the structure of pRSV-anti-t~-HCG is sche- 
matically presented in Fig. 1. The recombinant plasmid pBR322 with t~-HCG 
eDNA insert (621 bp) was agift from Dr. J. C. Fiddes of California Biotech- 
nology, Inc. (Mountainview,  CA) (10). The expression vector pRSV-/3-Globin 
(13) was Obtained from the American Type Culture Collection, Rockville, 
MD. The u-HCG-cDNA was inserted at the Hind III site of the plasmid 
pBR322 (10).  The recombinant plasmid was initially cleaved with Hha I 
(-58 bp) followed by treatment with the large fragment of the DNA poly- 
merase I (Klenow; New England Biolabs, Beverly,  MA). This a-HCG- 
eDNA fragment was then released from the plasmid by treatment with Hind 
III. These enzymatic treatments generate a o~-HCG-cDNA fragment with 
the blunt end at the 5' end and with a Hind III recognition site at the 3' end 
of the DNA molecule. The expression vector pRSV-/3-globin DNA was 
treated with the restriction endonuclease Bgl II, followed by generation of 
the blunt ends with the Klenow fragment ofDNA polymerase I. The/3-glo- 
bin sequence was then released from the plasmid backbone by digestion 
with Hind III. The 3' Hind III end of the cDNA-~-HCG sequence was then 
ligated to the Hind III site downstream of the RSV long terminal repeat se- 
quence of the linear plasmid. The recombinant plasmid was then recireu- 
larized by blunt end ligation (22). The orientation of the cDNA-a-HCG in 
the constructed recombinant plasmid was established by digestion with re- 
striction endonucleases followed by Southern blot analysis (33). 
The characterization of the expression vector pRSV-anti-a-HCG was 
focused to establish that the Hind Ill end (Y) of the ct-HCG-cDNA was 
ligated to the Hind III site located immediately downstream of the RSV pro- 
rooter sequence (Fig. 1). This was confirmed by digestion of pRSV-anti-ct- 
HCG with the restriction endonucleases, Eco RI and Xba I, followed by 
identification of a 485-bp DNA fragment which hybridizes with 32P-labeled 
ot-HCG-cDNA probe. Alternative orientation of the inserted ~-HCG-cDNA 
would not have generated such a  fragment. 
DNA-mediated  Transfer of  pRSV-Anti-~-HCG into 
ChaGo and L Cells 
The recombinant plasmid pRSV-anti-ct-HCG was transferred to L cells and 
ChaGo cells by a  calcium phosphate precipitation method originally de- 
scribed by Wigler et al. (40) and subsequently modified by us (27). The ex- 
pression vector pRSV-Neo (13) was cotransferred with pRSV-anti-a-HCG 
and G418-resistant transfectants were selected in the presence of 300 #g/ml 
of Geneticin ((3418; Sigma Chemical Co., St.  Louis, MO) for L cells or 
in the presence of 200 #g/ml for ChaGo cells. The ChaGo cell transfectants 
were selected in the presence of 100 ng/ml of t~-HCG because we antici- 
pated that the growth of anti-a-HCG-expressing transfectants may be de- 
pendent on the hormone. However, subsequent characterization of the trans- 
fectants demonstrated that although the ce-HCG antisense RNA-producing 
transfectants were very slow growing, they could not be further stimulated 
by addition of a-HCG in the culture medium. 
Other transfectants of ChaGo cells were also obtained with pRSV-Neo 
plasmid alone and together with another plasmid, pRSV-globin (13).  A 
comparative analysis was conducted of the transfectants with pRSV-Neo 
alone, with pRSV-Neo plus pRSV-globin, and with pRSV-Neo plus pRSV- 
anti-ct-HCG. Since the plasmid backbone of all three expression vectors 
was the same, transfectants with pRSV-Neo and pRSV-globin served as a 
control for the influence of pRSV-anti-a-HCG. Stable expression of the 
transferred genes suggested that these externally introduced plasmids were 
integrated stably into the chromosome of the recipient cells. The observed 
frequency of transfection of the plasmid pRSV-Neo was 2  x  10  -5  for 
ChaGo cells and 1.5  ×  l0  -4 for L cells. The cotransfection frequency of 
pRSV-anti-ct-HCG or pRSV-globin with pRSV-Neo was in the order of 
40%  in ChaGo cells as calculated from the identified a-HCG antisanse 
RNA or globin mRNA products in the G418-resistant transfectants. 
Measurement of  Levels of u-HCG-specific Sense and 
Antisense RNA in the Transfectants 
RNA from recipient cells and transfectants grown in complete medium was 
isolated  by  the  guanidinium  isothiocyanate method (22).  The  c~-HCG- 
specific sense and antisense RNA species in the total RNA was identified 
by Northern blot analysis followed by hybridization with strand-specific 
riboprobes. Human fetal lung tissue was obtained through the courtesy of 
Dr.  Frederick Bieber of Brigham and Women's Hospital (Boston, MA). 
The  strand-specific riboprobes  were  synthesized  from  recombinant 
phagemid (Bluescript;  Stratagene,  La Jolla,  CA) in which the a-HCG- 
eDNA was inserted at the Hind III site between the two bacterial RNA poly- 
merases (T7 and T3). The orientation of the inserted o~-HCG-cDNA in the 
Bluescript was established by restriction endonuclease digestion analysis and 
from the hybridization characteristics of the in vitro-synthesized [32p]RNA 
products of T3  and  T7  polymerase with cellular c~-HCG-mRNA.  The 
[32p]RNA  probe synthesized from c~-HCG-Bluescript DNA in the pres- 
ence of T3 polymerase (designated as probe T3)  recognized the cellular 
a-HCG-specific mRNA sequences (sense RNA); and the probe synthesized 
in the presence of polymerase T7 (designated as probe T7) did not recognize 
ct-HCG-mRNA  sequence  but  did  recognize  the  pRSV-anti-a-HCG- 
specific RNA sequences. 
The mouse H3.2 eDNA (32) was provided by Arthur B. Pardee of the Dana 
Father Cancer Institute (Boston, MA) and the recombinant plasmid with 
human c-myc-cDNA (35)  was made available to us by Dr. Philip Leder of 
the Department of Human Genetics, Harvard Medical School (Boston, MA). 
Measurement of a-HCG Level in ChaGo Cells 
and Transfectants 
The clonal strain of ChaGo cells which synthesizes predominantly u-HCG 
and very low levels of/ff-HCG was used in this investigation (34).  The 
a-HCG level in the culture medium was determined by radioimmunoassay 
as originally described by Vaitukaitis et al. (36) and subsequently modified 
by Tashjian et al. (34). The polyclonai c~-HCG-specific  antibody was ob- 
tained as a gift from the Hormone Distribution Agency (National Institutes 
of Health (NIH), Bethesda, MD). The specificity of the antibody was veri- 
fied by  immunoprecipitation of the hormone in the culture medium of 
[35S]methionine-labeled  ChaGo cells. Immunoprecipitated radioactive  mate- 
rial was then analyzed by SDS-PAGE and radioactive u-HCG was identified 
by comparison with the electrophoretic  mobility of authentic nonradioactive 
ct-HCG (obtained from Hormone Distribution Agency, NIH) anal,~lzed un- 
der identical conditions. 90% of the immunoprecipitated radioactivity was 
eliminated by performing the immunoprecipitation reaction in the pr~,sence 
of excess (200 ng) nonradioactive c~-HCG. Excess amounts of/~-HCG did 
not compete with this immunoprecipitated radioactive material. 
[3H]Thymidine Incorporation and Autoradiography 
5  ×  104 cells were plated in 35-ram tissue culture dishes in F10 medium 
(supplemented with 10%  fetal bovine serum). 48 h later the medium was 
removed and replaced with 2 ml of fresh medium. [3H]Thymidine (2 #Ci/ 
ml) was added to each of these plates and incubated at 37°C in a C(h (5%) 
incubator for the specified time. After the incubation period, the medium 
was removed and cells were washed free of [~H]thymidin¢ with Hanks 
buffered saline, fixed with methanol/acetic acid (3:1),  and covered with a 
thin layer of Kodak emulsion (Eastman Kodak Co., Rochester, NY) (1:1, nu- 
clear track emulsion). Autoradiography was carried out at room tempera- 
ture for 72-96 h. The dishes were developed with Kodak D19 developer and 
fixed with Kodak fixer.  They were then examined under a phase-contrast 
microscope and photographed. 
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Figure 1.  Construction  of the pRSV-anti-c~-HCG. 
Construction  protocol of the  recombinant plasmid 
pRSV-anti-ot-HCG is described schematically. The 
details are included in Materials and Methods. The 
left  side  of the  figure  shows the  isolation  of the 
o~-HCG-cDNA insert  fragment  from the  recom- 
binant  plasmid  pBR-t~-HCG (10). The right  side 
shows the structure  of the parent plasmid,  the ex- 
pression vector pRSV-globin used for the construc- 
tion of pRSV-anti-a-HCG. The stepwise treatment 
of these two plasmids is indicated by the arrows. The 
restriction endonuclease treatments were carried out 
under conditions  specified by the suppliers.  Treat- 
ment was with the Klenow fragment of Pol I and 
blunt-end  ligation  was performed as described  by 
Maniatis  et  al.  (22).  The  orientation  of inserted 
a-HCG-cDNA in the pRSV-anti-o~-HCG was es- 
tablished by restriction  endonuclease mapping and 
Southern blot analysis (33) of the plasmid DNA. 
Results 
Inhibition of  Anchorage-independent Growth 
Phenotype of ChaGo Cells by Anti-a-HCG Antibody 
Addition of anti-c~-HCG antibody to the top agar inhibited 
the growth of ChaGo cells on soft agar (Fig. 2). The colony 
forming efficiency of ChaGo cells on soft agar decreased as 
a function of the ot-HCG antibody concentration in the top 
agar  (Fig.  2,  B-D).  This  inhibitory  effect  was  partially 
reversed by addition of ot-HCG in the top agar along with the 
anti-~-HCG antibody (Fig. 2, E-G). Neither/3-HCG anti- 
body nor the gamma globulin fraction of the rabbit serum 
caused inhibition of growth of ChaGo cells on soft agar (data 
not shown). Addition of the ~-HCG in the top agar did not 
reverse the growth inhibiting effect of c~-HCG antibody. The 
growth of ot-HCG-nonproducing cell line SSC  15 (30) was 
not affected by t~-HCG antibody. All these results suggested 
that the loss of the anchorage-independent growth phenotype 
of ChaGo cells was due to the cell deprivation of one of its 
own products, the t~-HCG. Addition of ot-HCG antibody to 
the tissue culture medium affected the growth of ChaGo cells 
but this effect was not as dramatic as that observed in the soft 
agar assay. 
The role of the ectopic synthesis of ot-HCG on the growth 
characteristics of the transformed ChaGo cells was also veri- 
fled by inhibiting the synthesis of ot-HCG and by the ct-HCG 
antisense RNA technique. This is accomplished by transfec- 
tion of ChaGo cells with a recombinant plasmid in which the 
c~-HCG-cDNA was inserted with a reverse orientation with 
respect to the reading direction of the RSV promoter. 
Expression of  pRSV-Anti-a-HCG in ChaGo Cells 
The  functional  state of plasmid expression  vector pRSV- 
anti-a-HCG  was  verified  in  both  L  and  ChaGo  cells  by 
DNA-mediated  transfection  studies.  The  [32p]RNA  probe 
designated by T7 was complementary to the a-HCG anti- 
sense RNA and the one designated by T3 was complemen- 
tary to the c~-HCG-specific sense RNA species. Among the 
12 ChaGo cell transfectants analyzed, nine in experiment 1 
(Fig. 3, A and C, lanes 1-9) and three in experiment 2 (Fig. 
3,  B  and D,  lanes 12-14), the expression of pRSV-anti-c~- 
HCG could be detected in five of the transfectants (Fig.  3, 
C and D, lanes 5, 6, 8, 12, and 13). The endogenous a-HCG- 
specific sense RNA can be detected in all the ChaGo cell 
transfectants (Fig. 3, A and B, lanes 1-9 and 12-15). The basis 
for the different levels of expression of the endogenous t~-HCG 
gene in different transfectants is not clear. The stable integra- 
tion of externally introduced recombinant plasmid DNA spe- 
cies may have influenced c~-HCG gene expression in some 
transfectants. The size of the [32p]T3 hybridizable sequences 
Rivera et al. Role of c~-HCG on Transformed Phenotype of Lung Cells  2425 Figure 2. Growth of ChaGo cells on soft agar plates embedded with anti-et-HCG antibody. 5  x  104 cells in top agar were overlayered 
on bottom agar and were incubated at 37°C in an atmosphere of 95 % air and 5 % CO2. The plates were examined by phase-contrast mi- 
croscopy and photographed.  A typical field is presented  in each panel. A shows colony formation by ChaGo cells on soft agar. 60%  of 
the seeded ChaGo cells (average from duplicate plates) formed colonies on soft agar. B, C, and D show that 12, 0.5, and 0.008 %, respectively, 
of  the seeded ChaGo cells formed colonies on soft agar in the presence of anti-c~-HCG antibody of  dilutions 1:25,000, 1:10,000, and 1:5,000, 
respectively. This growth inhibition by ct-HCG-specific antibody (1:5,000) could be reversed by 50 ng/ml (E, 2%),  100 ng/ml (F,  11%), 
and 200 ng/ml ((3, 25 %) of c~-HCG in the top agar. (H) Same number of NIH 3T3 cells were plated. The alpha subunit of HCG (c~-HCG) 
and the ot-HCG-specific antibody (RIA grade) are gifts from the Hormone Distribution Agency (NIH). The colony forming efficiency of 
ChaGo cells and ChaGo cell transfectants were quantitated by counting the number of colonies (of a diameter i>0.2 mm) per plate (5  x 
104 ceils) 28 d after seeding.  Results are expressed as the percent of colonies  formed per total number of seeded cells per plate. 
was the same as the one identified by [32p]cDNA-~-HCG- 
hybridizable sequences in ChaGo cells; i.e., the same as that 
of u-HCG-specific mRNA (0.96 kb; Fig.  3 A, lane 10). In 
L  cells,  c¢-HCG  sense RNA  (T3  hybridization)  sequences 
were not detected (Fig. 3 A, lane//). The size difference be- 
tween the sense (0.96 kb) and the antisense RNA (1.40  kb) 
is believed to be due to the structural organization of the ex- 
ternally introduced plasmid vector pRSV-anti-ot-HCG and 
incomplete processing of its RNA transcripts. 
Expression of  pRSV-Anti-a-HCG in L Cells 
As a control, the same maneuvers were carried out in L cells, 
which do not synthesize ct-HCG. No ct-HCG-specific mRNA 
sequences (T3 hybridizable) were detected in L  cells (Fig. 
3, compare A, lane//, with E, lanes 3-8) suggesting that this 
gene was not active in L  cells.  However, c~-HCG antisense 
RNA sequences were detected in seven out often L cell trans- 
fectants derived by cotransfection of pRSV-anti-c~-HCG and 
pRSV-Neo (Fig. 3 E, lanes 9-18). These sequences appeared 
to be pRSV-anti-tx-HCG transcripts,  since they hybridized 
with  [32p]cDNA-ot-HCG  and  with  [32p]T7. These  RNA 
products do not seem to be the products of the endogenous 
gene activated by the  integration of foreign DNA into the 
mouse L cell chromosome. The size of the antisense RNA 
species in L cells was the same as that observed in ChaGo 
cell transfectants (Fig.  3  E,  lane 2). 
The results above demonstrate that the constructed expres- 
sion vector, pRSV-anti-ot-HCG, is active in cells that ectopi- 
cally synthesize c~-HCG, as well as in cells that do not pro- 
duce the hormone. 
c~-HCG Production by pRSV-Anti-a-HCG-expressing 
Transfectants 
The  influence  of t~-HCG antisense  RNA  on the  hormone 
production by ChaGo cells was examined by measurement 
oft~-HCG in the culture medium of transfectants. The c~-HCG 
level in the culture medium of the five pRSV-anti-a-HCG- 
expressing transfectants  (NH17,  NH18,  NH22,  NH23,  and 
NH24) was significantly lower than the level in the parental 
strain (Table I). Though these five transfectants synthesize 
significant amounts of ct-HCG-specific mRNA, the c~-HCG 
antisense RNA species in the same transfectants has effec- 
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antisense mRNA-c~-HCG in ChaGo cell 
and  L  cell  transfectants.  Cellular  total 
RNA was isolated and analyzed by the 
Northern blotting technique (33). 50 tzg 
of RNA was loaded in each lane. A  and B 
show the [32P]T3 hybridizable sequences 
(c~-HCG sense  RNA)  in  ChaGo  cell 
transfectants with pRSV-Neo and pRSV- 
anti-~-HCG (A, lanes 1-9, and B, lanes 
12-14). In B, lane 15, RNA from a trans- 
fectant  derived  with  pRSV-Neo  alone 
was applied. In A, lanes 10 and//, RNA 
from ChaGo cells and L cells were ap- 
plied,  respectively.  C and D  show the 
[32p]T7 hybridizable sequences (a-HCG 
antisense RNA) of the same amounts of 
RNA samples analyzed under  identical 
conditions.  E  shows the  [32P]c~-HCG- 
cDNA hybridizable sequences in L cell 
transfectants.  In  E,  lanes  3-8 contain 
RNA from transfectants with pRSV-Neo 
alone and lanes 9-18  contain RNA from 
transfectants with pRSV-Neo and pRSV- 
anti-c~-HCG. E, lanes 1 and 19, contain 
RNA from L cells and ChaGo ceils, re- 
spectively. RNA from one of the ChaGo 
cell transfectants, NH17, was applied in 
E, lane 2. 
Table L HCG Production by ChaGo Cells 
and Transfectants 
ct-HCG 
antisense  t~-HCG 
Strains  Donor DNA  RNA  (ng//xg cell  DNA/day) 
ChaGo  None  -  10.02 
NH17  pRSV-Neo  and  +  0.56 
pRSV-anti-a-HCG 
NH18  ....  +  1.05 
NH22  ....  +  0.86 
NH23  ....  +  0.67 
NH24  ....  +  0.78 
NH3  "  "  -  9.89 
NH4  .....  10.90 
NH5  ....  -  9.72 
N23  pRSV-Neo  -  10.56 
NG3  pRSV-Neo  and 
pRSV-Glb  -  9.53 
NG5  ....  -  11.02 
1  ×  103 cells were plated in 35-mm tissue culture dishes in 2  ml of complete 
medium. The next morning the medium was removed and 2  ml of fresh medi- 
um was added. The medium was changed every 2 d  thereafter till the date of 
withdrawal for analysis on day  10 of growth.  The  HCG production by the 
transfectants in the culture media was quantitated by radioimmunoassay (34, 
36). A  polyclonat antibody and the RIA-grade authentic a-I-ICG was obtained 
as a  gift from the National Hormone Distribution Agency). The  ~2~I-c~-HCG 
and all the other reagents were obtained from Cambridge Medical Diagnostics 
(Billerica, MA). Cellular DNA content in each plate (on the day of withdrawal 
of the  media)  was  measured as  described previously (27).  (-)  Absence of 
ct-HCG  antisense  RNA;  (+)  presence  of  ct-HCG  antisense  RNA.  NHI7, 
NH 18, NH22, NH23, and NH24 were pRSV-anti-a-HCG-expressing ChaGo 
cell transfectants. In  NH3,  NH4,  and NH5 were G418-resistant ChaGo cell 
transfectants but c~-HCG antisense RNA  was not detected  in these  transfec- 
tants. N23 was a G418-resistant transfectant which was derived by transfection 
of only the pRSV-Neo plasmid and NG3 and NG5 were G418-transfectants of 
ChaGo cells in which globin mRNA was detected. 
tively blocked the synthesis of ot-HCG. The level of u-HCG 
synthesis  was  not  affected  in  the  globin  gene  expressing 
G418-resistant transfectants (Table I). 
Influence of  Expression of  pRSV-Anti-a-HCG 
on the Morphology and Growth Characteristics of 
ChaGo Cells 
Transfection of pRSV-anti-c~-HCG drastically  affected the 
morphology and growth pattern of ChaGo cells. The trans- 
fectants,  expressing  pRSV-anti-ot-HCG  were  very  much 
stretched, flattened, and multinucleated in comparison to the 
parental strain (Fig. 4).  The postmitotic round cells which 
could be seen among the ChaGo cell population (Fig. 4 A) 
were practically absent in the pRSV-anti-~-HCG-express- 
ing transfectants NHI7, NH18, and NH23 (Fig. 4, B, C, and 
D, respectively). The morphology of the transfectants with 
pRSV-Neo  and  pRSV-globin  genes  were  comparable  to 
those of ChaGo cells. The morphology of the pRSV-anti-ct- 
HCG-expressing transfectants were characteristic of resting 
cells. In fact, despite similar plating efficiencies, the growth 
rate  of transfectants  was  significantly  lower  than  that  of 
ChaGo cells, especially when the plating density was very 
low (Fig. 5 A). The transfectants NHI7, NH18, and NH22 re- 
mained quiescent during 10 d of growth in tissue culture con- 
ditions,  but  not  because  of  nutritional  deficiency  (fresh 
medium was supplied every 3 d).  Under these conditions, 
ChaGo cells doubled  at their usual  rate of 80-96  h.  The 
growth  could be accelerated by increasing  the  number of 
seeding cells (Fig. 5, B and C). Supplementation with ot-HCG 
or  with  HCG (200  ng/ml) did  not  significantly  affect the 
growth rate of these transfectants. Since serum can shift cells 
Rivera et al. Role of c~-HCG on  Transformed Phenotype of Lung Cells  2427 Figure 4. Morphology of ChaGo cells and transfectants. 1 x  105 cells were plated in 60-mm tissue culture dishes in complete medium 
(Ham's FI0 medium supplemented with 10% fetal bovine serum). Cells were incubated in the CO2 incubator under conditions described 
above. Cells were fed with fresh medium every fourth day. Photographs were taken under a phase-contrast microscope at 10x. ChaGo 
cells were photographed after 10 d of growth, whereas the pRSV-anti-c~-HCG-expressing  transfectants, NH17, NH18, and NH23, were 
photographed after 18 d of growth. 
from a  nonproliferating to a proliferating stage,  additional 
serum (up to the concentration of 30%) was added to the cul- 
ture medium  of transfectants.  This  supplement-stimulated 
growth, which is in line with the morphologic evidence for 
the quiescent nature of a-HCG antisense-producing ChaGo 
cell transfectants (Fig. 5, D and E). Transfection of pRSV- 
anti-o~-HCG did not affect the morphology or growth rate of 
L  cells. 
Stimulation of u-HCG Sense RNA Synthesis 
by &Bromo-cAMP and Its Effect on the Growth 
Phenotypes of a-HCG Antisense RNA-producing 
ChaGo Cell Transfectants 
In seeking to elevate the level of ct-HCG-specific mRNA, 
ChaGo cells and ChaGo cell transfeetants were exposed to 
8,bromo-cAMP which stimulates the synthesis of c~-HCG- 
specific mRNA  in other ct-HCG-producing cells,  such as 
BEWO (human choriocarcinoma) cells (6, 31). This treatment 
resulted in an elevated level of c~-HCG-specific mRNA syn- 
thesis (sense RNA) in ChaGo cells and also in transfectants 
(Fig.  6 A, top). The synthesis of ot-HCG antisense RNA, 
which is driven by the RSV promoter in the transfectants 
NH17 and NH18, was not affected by such treatment (Fig. 6 
A, middle), nor was the expression of the ot-tubulin gene 
(Fig. 6 A, bottom). When transfectants that express the pRSV- 
anti-tx-HCG were  exposed to  8,bromo-cAMP,  they  were 
shifted from the  resting to  growing phase  (monitored by 
pH]thymidine incorporation; Fig. 6 B), and recovered their 
anchorage-independent  growth  phenotype  (as  shown  by 
colony formation on soft agar;  Table II). 
pH]Thymidine Incorporation 
The  rate  of  [3H]thymidine  incorporation  into  DNA  has 
been used as an index of the number of cells in S phase. The 
proportion of ChaGo cells in S phase was much higher rela- 
tive to that of t~-HCG  antisense RNA-producing transfec- 
tants (50-55 % for ChaGo ceils [Fig. 6 B, middle], and only 
15-20%  in NH17 and NH18 [Fig. 6 B, top and bottom]). 
8,Bromo-cAMP  treatment  of the  transfectants  stimulated 
[3H]thymidine incorporation in  these  cells  (Fig.  6  B,  +; 
NH17, 60%, and NH18, 67%). The G1/S block, which was 
observed in NH17 and NH18, was reversed by increased synthe- 
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Figure 5. Growth rate of ChaGo 
cells  and  transfectants.  ChaGo 
cells, the pRSV-anti-a-HCG-ex- 
pressing tranffect~ts NHI7, NH18, 
NH22, and NH23, and the pRSV- 
Neo-expressing  (only)  transfec- 
tant N23  were plated  in 35-mm 
tissue  culture  dishes  in  2 ml of 
complete medium and were incu- 
bated  under  CO2. The  medium 
was  replaced  by  serum  minus 
medium after 24 h and by com- 
plete medium after another 48 h. 
Plates  were  examined thereafter 
as indicated. The c~-HCG  level in 
the  medium  was  determined  as 
described in Materials and Meth- 
ods. Ceils were washed with Hanks 
buffered saline, and scraped and 
resuspended in 1 ml of water. Cell 
extracts were prepared by sonica- 
tion followed by centrifugation at 
1,000 g for 5 min in a refrigerated 
centrifuge.  DNA  content  in  an 
aliquot  was determined  by fluo- 
rometry. Plating density: (A) 1 x 
104; (B) 5  x  104; (C)  1 ×  105 
cells/prate in 10% serum-contain- 
ing medium; (D) 5  x  104 cells/ 
plate  in  30%  serum-containing 
medium; and (E) 1 x  105 cells/ 
plate  in  30%  serum-containing 
medium. 
sis of ot-HCG-mRNA, which presumably increased produc- 
tion of the hormone. Treatment with 8,bromo-cAMP increased 
the intracellular ratio of sense to antisense RNA species. The 
presumed resultant increase in the intracellular level of u-HCG 
apparently drove the G1/S-blocked cells into the S phase. 
Growth on Soft Agar 
That the a-HCG level influenced growth was further sup- 
ported by experiments on the anchorage-independent growth 
phenotype of both control and 8,bromo-cAMP-treated trans- 
fectants.  The transfectants NH17 and NH18 which did not 
form colonies on soft agar did so in the presence of 8,bromo- 
cAMP (Table II). Addition of anti-c~-HCG antibody inhib- 
ited  the  8,bromo-cAMP-induced  stimulation of growth  of 
NH17 and NH18 on soft agar which suggests that the stimu- 
lated growth resulted from the increased intracetlular synthe- 
sis of the hormone. In light of the similar behavior of ChaGo 
cells, it is concluded that the anchorage-independent growth 
phenotype of ChaGo cells and NH17 and NH18 is linked, ei- 
ther directly or indirectly, to the net level of o~-HCG synthesis 
by these cells. 
The Level of  Expression of Cell Proliferation- 
dependent Histone H3.2 Gene  and c-myc Gene in 
ChaGo Cells and in pRSV-Anti-~-HCG- 
expressing Transfectants 
The level of histone (H3.2) gene expression increases in par- 
allel  with  increased  cell proliferation  (4,  7,  14,  16).  The 
influence of the synthesis of ot-HCG antisense RNA on the 
proliferation of ChaGo cells was verified by monitoring the 
expression of the histone  H3.2  gene.  Results presented  in 
Fig. 7 A demonstrate that the level of expression of H3.2 gene 
Rivera et al. Role of c~-HCG on Transformed Phenotype of Lung Cells  2429 Figure 6. Influence of 8,bromo-cAMP on the synthesis of u-HCG-specific  sense and antisense RNA and [3H]thymidine incorporation  in 
control and treated ChaGo cells and transfectants. ChaGo cells and the pRSV-anti-c~-HCG-expressing transfectants, NHI7 and NH18, were 
grown as described  in Materials and Methods.  (A) Northern  blot analysis of RNA isolated from control (-) and 8,bromo-cAMP-treated 
(1 mM for 48 h;  +) cells.  25 #g of total RNA was applied to each lane. Top autoradiograph  shows the levels of o~-HCG-specific  sense 
RNA (hybridizable by [32p]T3 riboprobe).  Middle autoradiograph  shows the levels of c~-HCG-specific antisense  RNA (hybridizable by 
[32p]T7 riboprobe).  The bottom autoradiograph shows the level of alpha 2-tubulin-specific  mRNA sequences (hybridizable by [32p]alpha 
2-tubulin  cDNA probe; see reference 1) in control (-) and treated (+) cells. The numbers on the right indicate the size in kilobase pairs 
(kb) of the specific RNA sequences. (B) Autoradiographs of [3H]thymidine incorporation  in control (-) and 8,bromo-cAMP-treated  (+) 
(1 raM) ChaGo, NHI7, and NH18 cells. Cells were incubated with 2 #Ci/ml of [3H]thymidine for 6 h, fixed, and autoradiographed under 
conditions described  in Materials  and Methods. 
in the transfectants NH17 (Fig.  7 A,  lane 2),  NH18 (Fig.  7 
A, lane 3), and NH22 (Fig. 7 A, lane 4) was reduced almost 
to that of the normal fetal lung tissue (Fig. 7 A, lane/) and 
was significantly lower than that observed in  ChaGo cells 
(Fig.  7 A,  lane 5).  Rehybridization of the same filter with 
[32P]c-myc probe demonstrated that the level of expression 
of this gene in all the three transfectants (Fig. 7 B, lanes 2, 
3, and 4) and in ChaGo cells (Fig. 7 B, lane 5) were similar. 
The overexpression ofc-myc gene in ChaGo cells that did not 
change with the transition of cells from growing to resting 
state suggested a  stable deregulation of the gene. 
Tumorigenic Potential of ChaGo Cells 
and pRSV-anti-t~-HCG-expressing Transfectants 
in Athymic Mice 
The tumorigenic potential of ChaGo cells and ct-HCG an- 
tisense RNA-producing transfectants was verified by implan- 
tation of these cells under the dorsal skin of athymic mice (Nu 
Nu mice, Frederick Cancer Center, Frederick, MD). Implan- 
tation of ChaGo cells (1  ×  106) once under the back skin of 
athymic mice (Nu Nu mice) induced palpable tumors within 
3 wk which grew vigorously within the next few weeks (Fig. 
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ChaGo Cells and ChaGo Cell Transfectants in the 
Presence of S,Bromo-cAMP in Soft Agar 
Additions  ChaGo  NHI7  NH18 
%  %  % 
None  52.0  0.004  ND 
Anti-et-HCG  antibody  0.01  ND  ND 
8,Bromo-cAMP  73.0  30.0  26.0 
8,Bromo-cAMP  and Anti-a-HCG antibody  2.4  ND  ND 
The colony forming efficiency was calculated as described in Materials and 
Methods. 5 x  104 cells were seeded in triplicate plates; the top agar in the 
presence of 8,bromo-cAMP  (1 mM), or anti-a-HCG antibody (1:2,500), or 
both. Colony  formation  in several fields were counted  and the percent  of colo- 
ny formation was calculated from a total of 500 colonies and single cells in 
these fields. Plates with no colonies (ND) were scanned for the entire area. 
8; examined and photographed 6 (6W) and 12 wk (12W)  after 
implantation).  Histological  examination  of the  tumor con- 
firmed these growths as epithelial cell carcinoma. No visible 
tumor was induced by NH17 and NH18 cells in any animals 
over the course of 6  wk (Fig.  8, top, 6W). After  12 wk,  a 
small tumorous growth appeared in only one of the animals 
that  had  received  NH17 cells  (Fig.  8,  bottom,  12W).  The 
tumorigenic potential of ChaGo cells was practically lost in 
the presence of a-HCG antisense  RNA, presumably due to 
the reduced intracellular  level of hormone synthesis. 
Discussion 
These findings suggested that the intracellular level of u-HCG 
in ChaGo cells is critical for certain transformation pheno- 
types. The depletion of u-HCG by extracellular or intracellu- 
lar manipulations had consequences. ChaGo cells lost their 
tumor phenotypes and exhibited those more characteristic of 
resting  normal  cells  such  as  altered  morphology,  reduced 
growth  rate,  less  mitosis,  loss  of anchorage-independent 
growth,  and loss of tumorigenicity in athymic mice. 
Hormones and growth factors regulate proliferation of eu- 
karyotic cells in a very subtle manner.  The appropriate site 
of synthesis, the site of action, and also the appropriate level 
of synthesis are the key determinants for the regulated growth 
of specific cell types under the influence of these physiologi- 
cal substances.  Regulatory mechanisms of cell proliferation 
may  thus  be  perturbed  significantly  by  inappropriate  and 
high levels of expression of these genes. Inappropriate gene 
expression leading to ectopic hormone production in varie- 
ties  of human  tissues  has  been  correlated  with  neoplastic 
transformation of specific cell types (26).  In this investiga- 
tion, we have attempted to establish a causal relationship be- 
tween c~-HCG production and growth regulation of ChaGo, 
a  cell  line  derived  from  a  bronchogenic  carcinoma.  Our 
results demonstrated that deprivation of ChaGo cells of the 
alpha subunit of  the hormone, either by c~-HCG-specific anti- 
body  or  by  the  expression  of  the  recombinant  plasmid 
pRSV-anti-a-HCG,  drastically affected the growth pattern 
Figure 7.  Level of expression 
of histone  H3.2 and c-Myc in 
ChaGo cells  and pRSV-anti- 
t~-HCG-expressing  transfec- 
tants.  The level of expression 
of histone  H3.2  gene  (A)  in 
ChaGo cells  (lane  5)  and  in 
transfectants  NH17  (lane  2), 
NHI8  (lane  3),  and  NH23 
(lane  4)  was  determined  by 
Northern blot analysis  of cel- 
lular total RNA (33). 50 #g to- 
tal  RNA was applied  to each 
lane.  The RNA samples  were 
denatured and electrophoresed 
on 1.4% agarose,  followed by 
blot  transfer  and  subsequent 
hybridization  with  [32PIH3.2 
probe,  and  then  autoradio- 
graphed. The same membrane 
filter was subsequently stripped 
of  the  [32p]H3.2  by  boiling 
three times  (15  min each) in 
distilled  water. The  stripped 
membrane was then rehybrid- 
ized  with  32p-labeled  c-myc 
(human  cDNA)  probe  (B). 
The arrows show the sizes  in 
kilobase pairs of the  specific 
RNA species.  In lane  1,  the 
same amount of denatured to- 
tal RNA from human fetal lung tissue was applied.  The lower section of  each panel demonstrates the densitometric scanning of  the autoradio- 
graphic signals  performed in a transmission densitometer with a 3-mm slit (EC Apparatus Corp., St. Petersburg,  FL). The peak height 
and area was integrated  in the Apple liE computer with the Zenith electrophoresis program. The numbers on top of each peak show the 
percent of peak area. 
Rivera et al. Role of c~-HCG on Transformed Phenotype of Lung Cells  2431 Figure 8. Tumorigenic potential of ChaGo and ChaGo cell transfectants (NH17 and NH18) in athymic mice. Athymic mice (Nu Nu mice 
from the Frederick Cancer Center) were housed in sterile cages separated from other animals.  1 ×  106 cells of each cell strain in 0.5 
ml sterile Hank's buffered saline were implanted under the back skin of the mice (in duplicate). The animals were examined routinely 
for palpable tumor growth. The top and bottom panels show the animals, as examined and photographed, 6 (6 W) and 12 wk (12 W) after 
sample implantation of the respective cell strains. 
of these cells. Continuous proliferation and the anchorage- 
independent growth phenotypes were lost by these cells con- 
current with the  synthesis of c~-HCG antisense  RNA  and 
reduced level of a-HCG production. The transition of  pRSV- 
anti-u-HCG-expressing cells from a continuously prolifer- 
ating state to the resting state was correlated with a reduced 
level of  expression of  the cell cycle-dependent  H3.2 gene and 
[3H]thymidine incorporation in the pRSV-anti-~-HCG-ex- 
pressing transfectants. The proportion of the cells entering 
S  phase  was  directly correlated with the level of ct-HCG 
production. 
The critical role of o~-HCG on the regulation of growth of 
ChaGo cells was more evident from the results of modulation 
of the  intracellular  ratio  of a-HCG-specific  sense  to  an- 
tisense RNA in favor of the former by 8,bromo-cAMP, which 
reestablished the transformation phenotypes in these cells. 
The 8,bromo-cAMP-induced growth stimulation of transfec- 
rants could be reversed by anti-ct-HCG antibody, suggesting 
that the observed growth stimulation was mainly due to the 
increased u-HCG production. 
The level of ct-HCG antisense RNA  synthesized by the 
transfectants,  though  significant,  was  not higher than  the 
level of endogenous sense RNA product. However, it seems 
that  this  level of antisense  RNA  was  sufficient to  inhibit 
significantly the  synthesis  of the protein product in  these 
cells.  It was  suggested that a  >50-fold higher level of an- 
tisense RNA over the endogenous sense RNA is required for 
the effective inhibition of synthesis of a  specific protein in 
other cell types (2, 17, 20, 24, 29, 37, 41). However, it is evi- 
dent from these results that different levels of antisense RNA 
synthesis was necessary in different cell types to achieve the 
effective inhibition of the synthesis of the target gene prod- 
uct. For example, in certain cell systems RNA duplexes in- 
duced the production of an unwinding protein, which might 
explain why such a high level of antisense RNA is necessary 
for the effective inhibition of specific protein synthesis in 
these cells (2, 29,  37).  It seems that the recipient cell type 
is a determining factor for the effective inhibition of protein 
synthesis by antisense RNA. 
The specificity of the a-HCG effect on the growth pheno- 
type of ChaGo cells was demonstrated by the results that (a) 
anti-oc-HCG antibody addition to a  ot-HCG-nonproducing 
human cell type (30); and (b) anti-a-HCG RNA synthesis 
in L cells in which no ct-HCG-specific mRNA could be de- 
tected did not affect the growth pattern of these cells. These 
results,  thus,  suggest  that  the  influence of c~-HCG  is  re- 
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hormone.  Though o~-HCG partially  reversed the antibody- 
induced inhibition of growth of ChaGo cells, the beta subunit 
of the  hormone  was  unable  to  do  so  demonstrating  the 
specificity of the antibody effect. Similarly, anti-/~-HCG an- 
tibody did not affect the growth phenotype of ChaGo cells, 
again suggesting that the observed growth modulation was 
mainly dependent on the ot-HCG concentration and not the 
/~-HCG level in the culture medium. Although external ad- 
dition of o~-HCG was  unable  to  reverse the  ct-HCG  anti- 
sense-induced growth inhibition, the increased intracellular 
level of the  subunit  by 8,bromo-cAMP  stimulated the cell 
proliferation. These results suggested that it is the intracellu- 
lar level of the specific hormone which influenced the overall 
growth pattern of ChaGo cells. As the number of cells in the 
total population entering S phase was significantly reduced, 
or stimulated concurrently with a reduced or increased level 
of a-HCG production by these cells, it may be postulated that 
the lowered level of c~-HCG led to a growth arrest,  presum- 
ably  before S  phase.  Although  a-HCG  reversed the  anti- 
body-induced  growth  inhibition  of ChaGo  cells,  the  hor- 
mone did  not  significantly  improve the growth pattern  of 
pRSV-anti-ot-HCG-expressing transfectants.  This, however, 
could be  achieved by  increasing  the  intracellular  level  of 
o~-HCG. These results suggested that intracellular concentra- 
tion of the hormone was the critical determinant of its pro- 
liferative signal, which probably was mediated via a cascade 
of events. In this case,  exogenously administered hormone 
may reverse the intracellular depletion caused by antibody 
presentation, but could not access the intracellular compart- 
ment to substitute  for endogenously produced hormone in 
antisense-blocked  cells.  The  inability  of externally  added 
a-HCG may be also due to the defective receptor mechanism 
through which the hormone action  is normally  mediated. 
The possibility that a-HCG antibody- and ct-HCG antisense 
RNA-induced growth effects were due to the altered level of 
/~-HCG  seems to be remote because neither of the effects 
could be reversed by addition of/3-HCG to ChaGo cells or 
to the o~-HCG antisense RNA-producing transfectants.  The 
overexpression of the c-myc gene, which is believed to be a 
Gl-specific event, may also play a very important role in the 
growth phenotypes of transformed ChaGo cells. Though the 
role of c-myc overexpression in ChaGo cells was not defined 
as yet, it may be postulated that the c-myc gene product and 
ot-HCG may work in synchrony.  The former may increase 
the number of cells in G1 and the latter drive the cells to S 
phase, similar to the one designated as a progression factor. 
Overexpression of both these genes, caused by the carcino- 
genic event, may maintain the continuous growth phenotype 
of ChaGo cells. While the level of deregulated overexpression 
of c-myc remained unaltered, reducing the level of ot-HCG 
alone blocked continuous proliferation and arrested the growth 
of these lung tumor cells, presumably in the G1/S junction 
of the cell cycle. Voluminous reports demonstrate extensive 
correlation of ectopic synthesis of HCG and subunits,  pre- 
dominantly ot-HCG, with tumors of different human tissues. 
Though the mechanism by which its effect is exerted on the 
continuous  growth  phenotype  of lung  tumor  cells  is  not 
clearly defined in molecular terms, experimental evidence is 
presented in this report which demonstrates a possible direct 
or indirect role of the ectopic synthesis of the glycoprotein 
hormone in the carcinogenic process. 
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